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Peroxisome proliferator-activated receptors (PPARs) are members of the nuclear receptors superfamily. The three subtypes,
PPARα,P P A R γ,a n dP P A R β/δ, are expressed in multiple organs. These transcription factors regulate diﬀerent physiological func-
tions such as energy metabolism (including lipid and carbohydrate metabolism), insulin action, and immunity and inﬂammation,
and apparently also act as important mediators of longevity and aging. Calorie restriction (CR) is the most eﬀective intervention
known to delay aging and increase lifespan. Calorie restriction aﬀects the same physiological functions as PPARs. This review
summarizes recent ﬁndings on the eﬀects of CR and aging on the expression of PPARγ, α,a n dβ/δ in mice and discusses possible
involvement of PPARs in mediating the eﬀects of murine longevity genes. The levels of PPARs change with age and CR appears to
prevent these alterations which make “PPARs-CR-AGING” dependence of considerable interest.
Copyright © 2007 M. M. Masternak and A. Bartke. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
THE PPAR FAMILY
Peroxisome proliferator-activated receptors (PPARs) are
members of the nuclear receptor superfamily that are
ligand-dependent transcription factors. The activation of
PPARs requires forming heterodimers with retinoid X recep-
tors (RXRs), which allow binding to their speciﬁc peroxi-
some proliferator response elements (PPREs) [1]. By bind-
ing to speciﬁc PPREs in enhancer sites of targeted genes,
PPAR/RXR heterodimers regulate their expression. PPAR
genes are known to be expressed in diﬀerent organs, includ-
ing reproductive organs, major insulin target organs (liver,
white adipose tissue, skeletal muscle), cardiac tissue, and
other. PPARs have a wide spectrum of actions which include
adipocyte diﬀerentiation, lipid metabolism, insulin sensiti-
zation, tissue injury and wound repair, inﬂammation, and
immunity.
There are three known subtypes in the PPAR superfam-
ily, each encoded by separate genes: PPARα,P P A R β/δ (also
known as PPARβ or PPARδ), and PPARγ. The most ex-
ploredgeneofthissuperfamilyandthemostadipose-speciﬁc
is PPARγ. There are two recognized isoforms of PPARγ:
PPARγ1a n dP P A R γ2. These isoforms are generated by al-
ternative splicing and alternate translation initiation [2–4].
Although PPARγ is the most recently cloned gene from
PPARs, it quickly drew attention as a target receptor for thi-
azolidinediones (TZDs), the drugs used as insulin sensitizers
in type 2 diabetic patients (5–8).
As its name implies, PPARα was the ﬁrst gene cloned
from this family. PPARα is mainly expressed in the liver,
skeletal muscle, heart, and kidney. In these organs, it reg-
ulates a wide variety of target genes involved in cellular
lipid catabolism. PPARα alters the expression of genes en-
coding enzymes involved in the fatty acid metabolic path-
way, which activate the regulation of fatty acids β and ω-
oxidation. These eﬀects are mediated by the presence of
PPREsthatareundertranscriptionalcontrolofPPARαinthe
promoterregionsofgenescodingfortheenzymesinvolvedin
this metabolic pathway [5]. The activation of PPARα in the
heart induces accumulation of myocardial lipids that leads
to other features of diabetic cardiomyopathy [6]. PPARα-
deﬁcient mice have increased levels of total and HDL choles-
terol [7].
The function of the third PPAR nuclear receptor,
PPARβ/δ, is still somewhat unclear. There are some indica-
tions that PPARβ/δ is involved in lipid metabolism [8], and
studies have shown that it plays an important role in epider-
mal maturation and skin wound healing [9, 10].2 PPAR Research
CALORIE RESTRICTION AND PPARs
Calorie restriction (CR) is of wide interest in the study of
aging. There are numerous studies showing that CR can im-
prove the health of individuals and help protect them from
disease. CR is also recognized as the most eﬀective interven-
tion known to delay aging and increase lifespan [11]. The
precise mechanisms of CR action on aging and longevity are
still not well established, but CR is known to reduce body
weight and the levels of plasma insulin, IGF-1, GH, glucose,
and thyroid hormone.
Calorie restriction is also known to alter expression of
large number of genes involved in lipid metabolism and in-
sulin signaling. Expression of many of the same genes is reg-
ulatedbyPPARsactingastranscription factors.Thissuggests
a possibility that PPARs mediate the eﬀects of CR or that
CR and PPAR/RXRs heterodimers activate the same signal-
ing pathways.
ACTION OF PPARs ON INSULIN SIGNALING
The agonists for PPARα and PPARγ are widely used in di-
abetes. The study of rats fed a high-fat diet (HFD) indi-
cated that PPARα and PPARγ agonists, WY14643 and pi-
oglitazone, respectively, decreased glucose and leptin lev-
els in plasma. The plasma levels of insulin and triglyc-
eride were also reduced in rats treated with PPARs ago-
nists in comparison to control animals; however, piogli-
tazone caused signiﬁcantly greater reduction in compari-
son to PPARα-agonist-treated and control rats [12]. How-
ever, activation of PPARγ caused signiﬁcant increase of body
weight, which is opposite to CR action. PPARα agonist did
not alter body weight and more importantly caused signif-
icant decrease of visceral fat weight in comparison to con-
trol and pioglitazone-treated rats [12]. This indicates that pi-
oglitazone improves insulin sensitivity more eﬀectively than
WY14643. However, weight gain caused by PPARγ ago-
nist is detrimental to the well-being of diabetic rats or hu-
mans.
DIET
The functions and characterization of PPARs suggest that
these nuclear receptors are strongly connected with the diet.
There is considerable evidence that various diets can aﬀect
P P A R sa c t i o ni nd i ﬀerent organs and that the responses to
diets can be mediated by their eﬀects on PPARs expres-
sion.
High-fatdiet
High-fat diet is known to induce insulin resistance and pro-
mote type 2 diabetes in laboratory animals. In rats and mice
HFD causes obesity and increases plasma insulin, glucose,
and leptin levels. In HFD-fed rodents, PPARs agonists im-
prove insulin sensitivity, presumably via activation of this
nuclear receptor.
PPARαandhigh-fatdiet
Studies of PPARα-null mice indicated that the deﬁciency of
this nuclear receptor can protect from insulin resistance in-
duced by HFD [13]. In this study the authors showed that
HFD increases body weight and plasma insulin level but only
in normal animals, with no alteration in PPARα-null mice.
Moreover, insulin tolerance test (ITT), glucose tolerance test
(GTT), and the calculated insulin resistance index indicated
that HFD caused insulin resistance in normal animals, with
no alteration of insulin signaling in PPARα deﬁcient mice
[13]. However, studies of PPARα-null mice subjected to fast-
ing indicated that PPARα deﬁciency can cause severe hypo-
glycemia [14, 15]. Moreover, most of PPARα target genes
were not altered in the liver and heart of fasted PPARα-null
mice in comparison to normal controls [15]. The authors
also reported that in PPARα deﬁcient animals fasting caused
hyperketonemia, hypothermia, and increase in plasma levels
of free fatty acids, which reﬂects inhibition of fatty acid up-
take and oxidation [14]. Concluding, PPARα participates in
glucose homeostasis which may be important to prevent hy-
poglycemiaunderfastingconditionorduringexercise.How-
ever, long-term metabolic stress such as HFD could become
negative for health by developing insulin resistance.
PPARγ andhigh-fatdiet
Similarly to PPARα deﬁciency, PPARγ deﬁciency in adipose
tissue (PPARγ-adiposeKO) was reported to protect from
obesity and insulin resistance caused by HFD [16]. Under
HFD, this tissue-speciﬁc PPARγ deﬁciency increased glucose
tolerance in comparison to control animals on HFD. More-
over, the levels of insulin and leptin were signiﬁcantly de-
creased in HFD-treated, PPARγ-adiposeKO mice in compar-
ison to normal animals subjected to the same diet. Inter-
estingly, the deﬁciency of PPARγ in adipose tissue resulted
in increased PPARγ mRNA levels in the liver when com-
pared to normal controls [16]. As stated by the authors, this
model suggests that improved insulin sensitivity under HFD
inPPARγ-adiposeKOmicecancoexistwithincreasedexpres-
sion of PPARγ in the liver.
Calorierestrictiondiet
Calorie restriction is known to improve insulin sensitivity,
lipid metabolism, health, and longevity. Calorie restriction is
known to act on PPARs [17]; however, the eﬀects are strik-
ingly organ dependent. Depending on the organ, we ob-
served a lack of changes, decrease or increase of PPARs ex-
pression in response to CR (Figure 1).
PPARs,CR,andtheliver
Data reported by our laboratory indicated that 30% CR did
not alter mRNA or protein levels of hepatic PPARγ in mice.
This ﬁnding suggested that improvement of insulin sensi-
tivity in mice by CR is not mediated by PPARγ in the liver
[18, 19]. However, hepatic PPARα mRNA and protein levelsM. M. Masternak and A. Bartke 3
PPARγ-RNA
PPARγ-protein
PPARγ-RNA
PPARγ-protein
PPARα-RNA
PPARα-protein
PPAR β/δ-RNA
PPAR β/δ-protein
RXR γ
RXR α
RXR β/δ
PPARα-RNA
PPARα-protein
PPAR β/δ-RNA
PPAR β/δ-protein
RXR γ
RXR α
RXR β/δ
PPARγ-RNA
PPARγ-protein
PPARα-RNA
PPARα-protein
PPAR β/δ-RNA
PPAR β/δ-protein
RXR γ
RXR α
RXR β/δ PPARγ-RNA
PPARγ-protein
A B
C D
CR
Figure 1: Eﬀects of calorie restriction (CR) on the expression of PPARs family genes in mouse: (A) liver, (B) skeletal muscles, (C) white
adipose tissue, and (D) heart. Arrows pointing up or down indicate statistically signiﬁcant increases or decreases (P<. 05). Lack of arrows
means no alteration.
were signiﬁcantly increased by CR in comparison to mice fed
with unlimited (ad libitum; AL) access to food. This ﬁnding
appears counterintuitive in view of the evidence that PPARα
deﬁciency prevents insulin resistance in mice subjected to
HFD [13]. However, the suggested involvement of PPARα in
glucose homeostasis could imply that the increase of PPARα
in mice subjected to CR is a mechanism protecting these an-
imals from hypoglycemia [14, 15]. Perhaps under conditions
of HFD the decrease of PPARα is adaptive, but when the
animals are subjected to CR, PPARα increases to facilitate
maintenance of normal glucose levels during the periods
when food is not available. Additionally, a recent study con-
ducted by Corton et al indicated that 19% of hepatic genes
involved in lipid metabolism, inﬂammation, and cell growth
which were altered by CR were dependent on PPARα.I n -
terestingly, some of these genes were altered by CR only in
normal mice but not in PPARα deﬁcient animals. Results
obtained in animals treated with a PPARα agonist indicated
overlap of genes inﬂuenced by CR and by a compound acti-
vating PPARα [20]. These important ﬁndings indicated that
PPARαplaysanimportantroleinmediatingtheactionofCR
[13, 20]. Corton et al also suggested that drugs activating the
PPARα-RXR-LXR axis can be potential CR mimetics [20].
The expression of the remaining member of the PPAR
family, PPARβ/δ, in the liver was signiﬁcantly decreased by
CR at both mRNA and protein levels [19]. Thus, the hepatic
expression of three genes from the PPAR family is diﬀeren-
tiallyalteredbyCR.However,CRdidnotalterhepaticRXRα,
RXRγ,a n dR X R β/δ mRNA (Figure 1A) [19].
PPARs,CR,andskeletalmuscle
Similarly to the liver, the skeletal muscle is a major insulin
target organ. In this tissue, the expression of PPARs and
RXRs is altered diﬀerently by CR than in the liver [19, 21].
It was reported that 30% calorie restriction in mouse skeletal
muscle decreased the level of PPARγ mRNA and the PPARγ
protein level appeared to also be decreased [21]. We could
speculate that the decrease of PPARγ in the muscle as seen
in the adipose speciﬁc knockout for PPARγ is beneﬁcial for
insulin sensitivity [16]. However, muscle-speciﬁc knockout
of PPARγ caused whole-body insulin resistance [22]. Inter-
estingly, treating these knockout mice with TZD improved
insulin sensitivity [22], suggesting the eﬀect was due to
PPARγ agonism in other tissues. This suggests that CR can
increase insulin sensitivity through eﬀects on PPARγ expres-
sion in tissues other than the muscle, and speculating fur-
ther we could suggest that under the conditions of CR, a de-
creased rather than elevated PPARγ expression is beneﬁcial.
PPARα m R N Aa n dp r o t e i n sw e r ed e c r e a s e db yC Ri n
skeletalmuscle,aneﬀectoppositetothatobservedintheliver
[19, 21]. It was speculated that a decrease of PPARα in the
muscleunderCRslowedfattyacidoxidation,thusincreasing
the reliance on carbohydrates as the energy source. More im-
portantly, consequences of reduced PPARα expression could
prevent the muscle from using all of the FFA immediately
after food intake and thus maintain a balance between en-
ergy availability and energy usage during the fasting pe-
riod. The protein level of PPARβ/δ was also decreased in the4 PPAR Research
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Figure 2: Eﬀects of growth hormone receptor/binding protein knockout (GHR-KO) on the expression of PPARs family genes in mouse: (A)
liver, (B) skeletal muscle, and (C) heart. Arrows pointing up or down indicate statistically signiﬁcant increases or decreases (P<. 05). Lack
of arrow means no alteration.
skeletalmuscleofCRmice[21].ItiswellknownthatCRpro-
motes fat depletion and prevents obesity. Studies in PPARδ-
deﬁcient mice on HFD revealed reduced energy uncoupling
and obesity [21]. This would predict that reduced levels of
PPARδ in the muscles of CR mice may lead to increased
lipid accumulation and promote obesity. However, reduced
dietaryfatintakeinCRanimalsmayaltertheserelationships.
It was suggested that CR down-regulates the pathway of lipid
metabolism and accommodates it to the circumstances of re-
stricted food intake [21]. This may serve to prevent disrup-
tion of fatty acid homeostasis in CR animals. In addition to
its eﬀects on PPARs expression, CR reduced mRNA levels of
RXRα and RXRβ/δ [21]. Altered expression of these genes
important to PPARs activation correlated with the changes
in the expression of the corresponding members of the PPAR
family (Figure 1B) [21].
PPARs,CR,andthewhiteadiposetissue
PPARγ is mainly expressed in white adipose tissue (WAT).
As mentioned previously, the deﬁciency of PPARγ in adi-
pose tissue is protective against obesity and insulin resistance
caused by HFD [16, 23]. However, CR increases insulin sen-
sitivityinmice,withoutalteringPPARγ mRNAlevelsinWAT
(Figure 1C) [24]. It can be speculated that under conditions
of reduced calorie intake diminished PPARγ would not be
beneﬁcial,orthatlimitedfatstoragedoesnotallowincreased
PPARγ activation in this tissue. At the time of this writing
no data are available on the eﬀects of CR on PPARα and
PPARβ/δ in WAT.
PPARs IN GENETICALLY LONG-LIVED AND
SHORT-LIVED MICE
Growthhormonereceptor/bindingprotein
knockout(GHR-KO)mice
GHR-KO (Laron dwarf) mice have their GH recep-
tor/binding protein gene disrupted and thus are deﬁcient of
GHR. Consequently these mice are GH resistant or insensi-
tive and have greatly reduced plasma IGF-1 and insulin lev-
els, and low glucose level [25, 26]. GHR-KO mice are also
characterized by markedly extended lifespan in comparison
to normal controls [27, 28].
In comparison to normal animals, GHR-KO mice also
have signiﬁcantly elevated PPARγ mRNA and protein level
in the liver (Figure 2A) [19]. We speculated that increased
level of PPARγ in the liver of those long-lived animals may
be responsible for or contribute to their exceptionally high
insulin sensitivity. This correlates with ﬁndings in PPARγ-
adiposeKO mice, which indicated that PPARγ deﬁciency in
WAT is compensated for by increased expression of this
nuclear receptor in the liver to promote insulin sensitivity
[16,19].TheﬁndingsinthemusclealsosuggestthatinGHR-
KO mice PPARγ in the liver contributes to high insulin sen-
sitivity, because the level of PPARγ mRNA in skeletal muscle
of KO mice was not altered, while the PPARγ protein level
was decreased in comparison to normal controls (Figure 2B)
[21].
The increased level of PPARα measured in the liver
of KO mice [19] could be suspect of exerting to negativeM. M. Masternak and A. Bartke 5
eﬀectoninsulinactionandobesity.However,thehigherlevel
of PPARα suggests an increased usage of fatty acids, which
could be beneﬁcial for insulin sensitivity. Increased PPARα
levels could also be correlated with decreased total choles-
terol level in GHR-KO animals [21]. It is interesting that
the level of PPARα in GHR-KO mice fed AL is maintained
at the same level as in the normal animals subjected to CR.
However, similarly to PPARγ, expression of PPARα was not
altered in the muscle at the PPARα mRNA level, while the
PPARα protein level was decreased in KO animals, again re-
sembling the ﬁndings in normal mice under a CR regimen
[21].
PPARβ/δ proteins were down-regulated in the liver and
skeletalmuscleofGHR-KOmice,whichinbothcasesmimics
the alterations of the expression of this gene caused by CR in
the liver and muscle of normal mice [21].
These data indicate that CR alters PPARα and PPARβ/δ
proteins and/or mRNA levels in the liver and skeletal muscle
to the levels maintained in GHR-KO animals. Since GHR-
KO mice are long-lived and CR increases longevity, it can
be suggested that PPARα and PPARβ/δ play an important
role in mediating the eﬀects of both GHR-KO and/or CR on
longevity. The RXRγ,R X R α,a n dR X R β/δ mRNA were in-
creased in the liver and not changed in the muscle of GHR-
KO mice which corresponds to alterations of PPARγ and
PPARα in these two organs (Figure 2A, B) [19, 21].
Dwarfmice
Snell dwarf, Ames dwarf, and “Little” mice live markedly
longer than their normal siblings. Snell dwarf mice carry a
mutation in the Pit1 gene (Pit1dw) and Ames dwarf mice are
homozygous for recessive loss-of-function mutation at the
Prop1 locus (Prop1df). These dwarf mice are deﬁcient with
GH, prolactin, and tyrotropin. Little mice have severely re-
ducedGHlevelscausedbythemutationofgrowthhormone-
releasing hormone receptor (Ghrhr). Studies of Snell dwarf
mice indicated increased hepatic PPARα mRNA and protein
levels in comparison to heterozygous controls [29]. The ex-
pression of PPARα mRNA and protein in the liver of Ames
dwarf mice was not altered in comparison to their normal
controls [18]. However, gene array studies indicated that the
genes regulated by PPARα were either up-regulated in Snell
dwarf, Ames dwarf, and Little mice or their expression in-
creased in response to PPARα-agonist treatment, which was
interpreted as evidence that GH action is involved in the reg-
ulation of PPARα-dependent gene products [29].
Phosphoenolpyruvatecarboxykinase
bovine-GHtransgenicmice
PEPCK-bGH transgenic (TG) mice over-expressing the bGH
gene fused to control sequences of the rat phosphoenolpyru-
vate carboxykinase (PEPCK) are characterized by markedly
shortened lifespan in comparison to their normal siblings
[30]. The ﬁndings in the liver did not indicate any alteration
of PPARγ mRNA in these TG mice. However, hepatic PPARα
mRNA was down-regulated in the liver of these short-living
giant mice in comparison to their normal siblings [30]. This
ﬁnding is very important in elucidating the potential role
of PPARα in the control of longevity. As mentioned above,
PPARα is increased in the liver of GHR-KO and CR mice.
This contrasts with the decreased PPARα level in the liver of
short-lived b-GH transgenic mice. These ﬁndings are con-
sistent with our suggestion that PPARα can be an important
mediator of genetic and dietary eﬀects on longevity.
AGING AND CALORIE RESTRICTION
As mentioned above, the study of PPARα-null mice indi-
cated that the deﬁciency of this nuclear receptor can protect
from insulin resistance induced by HFD [13]. Furthermore,
we speculated that PPARα can be inﬂuential in the control
of longevity, and we suggested that an elevated level of this
n u c l e a rr e c e p t o ri sb e n e ﬁ c i a la n dp r o m o t e sl o n g e rl i f e .A l -
though PPARα deﬁciency was useful in controlling glucose
levels in HFD-fed mice, it was reported that these mice had
age-dependent defects in heart, liver, and kidney, which cor-
related with decreased longevity in comparison to wild-type
controls [31, 32]. PPARα expression is also known to de-
crease with age in the liver, kidney, and heart. The study of
GHR-KO and normal mice fed AL and subjected to CR in-
dicated that PPARα mRNA level in the heart is not aﬀected
byphenotypeandCR(Figures1Dand2C)[33].CRincreases
themRNAandproteinlevelofPPARαonlyinGHR-KOmice
[33]. Interestingly, protein level of PPARα was decreased in
the heart of long-lived GHR-KO animals (Figure 2C) [33].
Moreover, earlier study [34] indicated that CR increased the
cardiac level of PPARα mRNA in mice, which would support
antiaging action. Analysis of gene expression in mouse heart
byLeeetalindicatedthatCRpreservedfattyacidmetabolism
[35]. Additionally, the study of GHR-KO mice indicated that
at the age of 3 months PPARα w a se l e v a t e di nK Oi nc o m -
parison to the normal mice. When the animals reached 21
months of age this diﬀerence was no longer present [33].The
short-lived b-GH TG mice showed down regulation of this
nuclear receptor in the heart at 9 months of age [33].
Sung et al reported that in rats the levels of PPARγ and
PPARα in the kidney decreased with age when comparing
13- and 25-month-old animals [36]. Calorie restriction pre-
vented these aging eﬀects and maintained the levels of these
nuclear receptors in 25-month-old rats at the same levels as
in the 13-month-old animals [36]. To investigate the possi-
ble role of PPARα and PPARγ in inﬂammation, these au-
thorsalsoperformedlipopolysaccharide(LPS)testsinyoung
and old rats. Treatment with LPS decreased the level of these
PPARs, to greater extent in old than in middle-age rats [36].
Theauthorsconcludedthatdown-regulationofPPARsinthe
rat’s kidneys might be correlated with age-related oxidative
stress, which could be reversed by antioxidative action of CR
[36].
SUMMARY
Diﬀerent members of the PPARs family are expressed in
many tissues. Various dietary regimens such as HFD and
calorie restriction can aﬀect expression of PPARs. However,6 PPAR Research
the presence and direction of these changes depend on the
organ being analyzed. Additionally, the eﬀects of the diet on
the animal depend on the actions of PPARs. For example,
PPARα-null or PPARγ-adiposeKO mice are protected form
insulin resistance and obesity caused by HFD. Studies in ge-
netically long- or short-lived mice together with the studies
involving CR suggest that PPARs play an important role in
insulin action, lipid metabolism, immunity, and inﬂamma-
tion as well as regulation of aging and longevity.
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